Primary tumors of the lung: should we consider thermal ablation as a valid therapeutic option?

Non-small cell lung cancer (NSCLC) remains the leading cause of cancer death; percutaneous thermal ablation (TA) has proven feasibility, good local control and good tolerance in stage I tumors for patients with medical comorbidities and who are ineligible for surgery. In this context, stereotactic b...

Full description

Bibliographic Details
Main Authors: Jean Palussière, Vittorio Catena, Philippe Lagarde, Sophie Cousin, Mathilde Cabart, Xavier Buy, François Chomy
Format: Article
Language:English
Published: Taylor & Francis Group 2019-10-01
Series:International Journal of Hyperthermia
Subjects:
Online Access:http://dx.doi.org/10.1080/02656736.2019.1647351